Alpine Immune Sciences, Inc.
At Close: 4:00 PM
ALPN Stock Price Graph
ALPN Stock Price Today
Alpine Immune Sciences, Inc. (ALPN) stock rallied over 1.01% intraday to trade at $15.07 a share on NASDAQ. The stock opened with a loss of -42.43% at $8.59 and touched an intraday high of $9.44, rising 1.01% against the last close of $14.92. The Alpine Immune Sciences, Inc. in stock market went to a low of $8.59 during the session.
ALPN Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
ALPN Stock Price History Chart
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
Frequently Asked Questions
What is the current Alpine Immune Sciences, Inc. (ALPN) stock price?
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) stock price is $15.07 in the last trading session. During the trading session, ALPN stock reached the peak price of $9.44 while $8.59 was the lowest point it dropped to. The percentage change in ALPN stock occurred in the recent session was 1.01% while the dollar amount for the price change in ALPN stock was $0.15.
ALPN's industry and sector of operation?
The NASDAQ listed ALPN is part of Biotechnology industry that operates in the broader Healthcare sector. Alpine Immune Sciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases.
Who are the executives of ALPN?
Mr. Paul Rickey
Senior Vice President, Chief Financial Officer, Treasurer & Sec.
Dr. Pamela Holland Ph.D.
Senior Vice President of Research
Head of IR & Corporation Communications
Dr. Mitchell H. Gold M.D.
Executive Chairman & Chief Executive Officer
How ALPN did perform over past 52-week?
ALPN's closing price is 0.42% higher than its 52-week low of $5.36 where as its distance from 52-week high of $14.92 is -0.31%.
How many employees does ALPN have?
Number of ALPN employees currently stands at N/A. ALPN operates from 188 East Blaine Street, Seattle, WA 98102, US.
Link for ALPN official website?
Official Website of ALPN is: https://www.alpineimmunesciences.com
How do I contact ALPN?
How many shares of ALPN are traded daily?
ALPN stock volume for the day was 180287.00 shares. The average number of ALPN shares traded daily for last 3 months was 584.29 Thousands.
What is the market cap of ALPN currently?
The market value of ALPN currently stands at $874.06 Million with its latest stock price at $15.07 and N/A of its shares outstanding.